Glycobiology Advance Access published online on June 9, 2004
Glycobiology, doi:10.1093/glycob/cwh104
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 GlycoFi, Inc, 21 Lafayette St, Suite 200, Lebanon, NH 03766, USA
* To whom correspondence should be addressed. E-mail: swildt{at}glycofi.com.
A significant percentage of eukaryotic proteins contain posttranslational modifications, including glycosylation, which are required for biological function. However, the understanding of the structure/function relationships of N-glycans has lagged significantly due to the micro-heterogeneity of glycosylation in mammalian produced proteins. Recently, we have reported on the cellular engineering of yeast to replicate human N-glycosylation for the production of glycoproteins. Here, we report the engineering of an artificial glycosylation pathway in the yeast Pichia pastoris blocked in dolichol oligosaccharide assembly. The PpALG3 gene encoding Dol-P-Man:Man5GlcNAc2-PP-Dol mannosyltransferase was deleted in a strain that was previously engineered to produce hybrid GlcNAcMan5GlcNAc2 human N-glycans. Employing this approach, combined with the use of combinatorial genetic libraries, we engineered P. pastoris strains that synthesize complex GlcNAc2Man3GlcNAc2 N-glycans with striking homogeneity. Furthermore, through expression of a Golgi localized fusion protein comprising UDP-glucose 4-epimerase and
Revised May 25, 2004
Accepted May 26, 2004
ORIGINAL ARTICLES
Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris - production of complex humanized glycoproteins with terminal galactose
![]()
Abstract
-1,4-galactosyl transferase activities we demonstrate that this structure is a substrate for highly efficient in vivo galactose addition. Taken together, this data demonstrate that the artificial in vivo glycoengineering of yeast represents a major advance in the production of glycoproteins and will emerge as a practical tool to systematically elucidate the structure/function relationship of N-glycans.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G.-C. Gil, W. H Velander, and K. E Van Cott Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk Glycobiology, July 1, 2008; 18(7): 526 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kainz, A. Gallmetzer, C. Hatzl, J. H. Nett, H. Li, T. Schinko, R. Pachlinger, H. Berger, Y. Reyes-Dominguez, A. Bernreiter, et al. N-Glycan Modification in Aspergillus Species Appl. Envir. Microbiol., February 15, 2008; 74(4): 1076 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Hamilton, R. C. Davidson, N. Sethuraman, J. H. Nett, Y. Jiang, S. Rios, P. Bobrowicz, T. A. Stadheim, H. Li, B.-K. Choi, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science, September 8, 2006; 313(5792): 1441 - 1443. [Abstract] [Full Text] [PDF] |
||||


